Life ScienceCompany
BioMarin Pharmaceutical M&A Summary
BioMarin Pharmaceutical has acquired 2 companies.
BioMarin Pharmaceutical’s largest acquisition to date was in 2014, when it acquired Prosensa for $680M. BioMarin Pharmaceutical has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
BioMarin Pharmaceutical Business Overview
Where is BioMarin Pharmaceutical headquartered?
BioMarin Pharmaceutical is headquartered in San Rafael, California.
What is BioMarin Pharmaceutical’s revenue?
BioMarin Pharmaceutical disclosed revenue of 1,846M USD for 2021 and 1,860M USD for 2020.
How many employees does BioMarin Pharmaceutical have?
BioMarin Pharmaceutical has 3,045 employees.
What sector is BioMarin Pharmaceutical in?
BioMarin Pharmaceutical is a life science company.
When was BioMarin Pharmaceutical founded?
BioMarin Pharmaceutical was founded in 1996.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2